Strong research and development programs are vital to the continued success of pharmaceutical and biotechnology companies in today's fiercely competitive markets. By Tsunamic Technologies
Boehringer-Ingelheim’s Thomas Zimmer on how pharma firms are improving their manufacturing processes.
How pharmaceutical manufacturers are stepping up to the cost-cutting challenge.